Tissuepathology.com

Proscia Wins 2026 MedTech Breakthrough Award for Turning the Moment of Diagnosis into Drug Development Insights

Erica Goodpaster — Fri, 08 May 2026 12:42:25 +0000

Proscia Honored alongside IQVIA, Medidata, and Thermo Fisher Scientific PHILADELPHIA — May 7, 2026 — Proscia®, a company bringing pathology to the center of precision medicine, has been named a winner in the 10th annual MedTech Breakthrough Awards, marking its second consecutive year of recognition. It was honored for enabling pharmaceutical companies to advance precision therapies […]

The post Proscia Wins 2026 MedTech Breakthrough Award for Turning the Moment of Diagnosis into Drug Development Insights first appeared on Tissuepathology.com.

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics

Erica Goodpaster — Thu, 07 May 2026 13:26:42 +0000

PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche’s digital pathology portfolio to drive laboratory efficiency Combining Roche’s strong position in companion diagnostics and PathAI’s advanced AI platform helps accelerate clinical therapy development, foster the discovery of new biomarkers, and create novel diagnostic tools These integrated capabilities will […]

The post Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics first appeared on Tissuepathology.com.

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Erica Goodpaster — Wed, 06 May 2026 12:03:35 +0000

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the launch of Caris MI Clarity™, the first prognostic test designed […]

The post Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis first appeared on Tissuepathology.com.

Join Indica Labs for Online Masterclass

Erica Goodpaster — Tue, 05 May 2026 12:26:03 +0000

Indica Labs: Learn how to unlock deeper insights and enhance your data using the HALO Spatial Analysis module Masterclass: Performing Spatial Analysis Workflows with HALO® Date: 19 May 2026 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 16:00 – 17:00 BST Location: Webinar Register Now Summary The HALO® Spatial Analysis module enables quantitative assessment of cellular […]

The post Join Indica Labs for Online Masterclass first appeared on Tissuepathology.com.

Connect with Deciphex in Dublin!

Erica Goodpaster — Mon, 04 May 2026 12:25:23 +0000

From Deciphex on LinkedIn: Next Tuesday, our CEO Donal O’Shea takes the stage at the MedTech Strategist Innovation Summit in Dublin. Donal will be joining the “Breaking In: Rolling out Medtech in Europe” commercialisation panel, sharing the hard-won perspective that comes from building and scaling AI-driven digital pathology across some of the world’s most complex […]

The post Connect with Deciphex in Dublin! first appeared on Tissuepathology.com.

Techcyte announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability

Erica Goodpaster — Fri, 01 May 2026 12:32:48 +0000

Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the completion of a $15 million capital raise led by Van Tuyl Companies, with participation from existing investors Zoetis Inc. (“Zoetis”) and Mayo Clinic. This funding reinforces Techcyte’s ability to execute on its strategic priorities and supports its path to […]

The post Techcyte announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability first appeared on Tissuepathology.com.